Universitätsklinikum Ulm

Inhibition of intercellular cytosolic traffic via gap junctions reinforces lomustine-induced toxicity in glioblastoma independent of mgmt promoter methylation status (2021) Schneider M, Potthoff AL, Evert BO, Dicks M, Ehrentraut D, Dolf A, Schmidt EN, et al. Journal article Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma (2021) Leich E, Schreder M, Pischimarov J, Stuhmer T, Steinbrunn T, Rudelius M, Bruennert D, et al. Journal article The IKZF1–IRF4/IRF5 axis controls polarization of myeloma-associated macrophages (2021) Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, et al. Journal article Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy (2021) Furlanetto J, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer JU, Lübbe K, et al. Journal article The Autophagy-Initiating Protein Kinase ULK1 Phosphorylates Human Cytomegalovirus Tegument Protein pp28 and Regulates Efficient Virus Release (2021) König P, Svrlanska A, Read C, Feichtinger S, Stamminger T Journal article Physician support for outpatient cardiac rehabilitation groups: Position paper of the German Cardiac Society (DGK) in cooperation with the German Society for Prevention and Rehabilitation of Cardiovascular Diseases (DGPR) Ärztliche Betreuung von ambulanten Herzgruppen: Positionspapier der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung (DGK) in Kooperation mit der Deutschen Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR) (2021) Wienbergen H, Schwaab B, Bjarnason-Wehrens B, Guha M, Laszlo R, Burgstahler C, Von Haehling S, et al. Journal article, Review article Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results (2021) Reinisch M, Nusch A, Decker T, Hartkopf A, Heinrich BJ, Kurbacher CM, Fuchs R, et al. Conference contribution Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial (2021) Fehm T, Mueller V, Banys-Paluchowski M, Fasching P, Friedl TWP, Hartkopf A, Huober J, et al. Conference contribution Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program (2021) Muller V, Banys-Paluchowski M, Friedl TWP, Fasching P, Schneeweiss A, Hartkopf A, Wallwiener D, et al. Journal article German Society of Residents in Urology (GeSRU) (2021) Siech C, Beck A, Fassbach M, Zehe , Wundrack F, Koenig J, Bellut L Journal article, Editorial